The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Design and Synthesis of Curcumin Analogues for in Vivo Fluorescence Imaging and Inhibiting Copper-Induced Cross-Linking of Amyloid Beta Species in Alzheimer’s Disease
Open accessAbstract
In this article, we first designed and synthesized curcumin-based near-infrared (NIR) fluorescence imaging probes for detecting both soluble and insoluble amyloid beta (Aβ) species and then an inhibitor that could attenuate cross-linking of Aβ induced by copper. According to our previous results and the possible structural stereohindrance compatibility of the Aβ peptide and the hydrophobic/hydrophilic property of the Aβ13-20 (HHQKLVFF) fragment, NIR imaging probe CRANAD-58 was designed and synthesized. As expected CRANAD-58 showed significant fluorescence property changes upon mixing with both soluble and insoluble Aβ species in vitro. In vivo NIR imaging revealed that CRANAD-58 was capable of differentiating transgenic and wild-type mice as young as 4 months old, the age that lacks apparently visible Aβ plaques and Aβ is likely in its soluble forms. According to our limited studies on the interaction mechanism between CRANAD-58 and Aβ, we also designed CRANAD-17 to attenuate the cross-linking of Aβ42 induced by copper. It is well-known that the coordination of copper with imidazoles on Histidine-13 and 14 (H13, H14) of Aβ peptides could initialize covalent cross-linking of Aβ. In CRANAD-17, a curcumin scaffold was used as an anchoring moiety to usher the designed compound to the vicinity of H13 and H14 of Aβ, and imidazole rings were incorporated to compete with H13/H14 for copper binding. The results of SDS-PAGE gel and Western blot indicated that CRANAD-17 was capable of inhibiting Aβ42 cross-linking induced by copper. This raises a potential for CRANAD-17 to be considered for AD therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Molecular mechanism of Thioflavin-T binding to amyloid fibrils
Biancalana, M., & Koide, S. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.04.001 · Cited by 2,195
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Stefani, M., & Dobson, C. M. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0464-5 · Cited by 1,651
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils
Paravastu, A. K., Leapman, R. D., Yau, W.-M., & Tycko, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806270105 · Cited by 1,160
Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrils
Ahmed, M., Davis, J., Aucoin, D., Sato, T., Ahuja, S., Aimoto, S., Elliott, J. I., Van Nostrand, W. E., & Smith, S. O. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1799 · Cited by 1,111
In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis
Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210207200 · Cited by 1,015
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., Prada, C., Greenberg, S. M., Bacskai, B. J., & Frosch, M. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.017 · Cited by 744
Lannfelt, L., Blennow, K., Zetterberg, H., Batsman, S., Ames, D., Harrison, J., Masters, C. L., Targum, S., Bush, A. I., Murdoch, R., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70167-4 · Cited by 725
Necula, M., Kayed, R., Milton, S., & Glabe, C. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608207200 · Cited by 680
Current and future treatments for Alzheimer's disease
Yiannopoulou, K. G., & Papageorgiou, S. G. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285612461679 · Cited by 677
Alzheimer's Disease: From Pathology to Therapeutic Approaches
Jakob‐Roetne, R., & Jacobsen, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802808 · Cited by 626
Hamley, I. W. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700861 · Cited by 618
Metalloenzyme-like Activity of Alzheimer's Disease β-Amyloid
Opazo, C., Huang, X., Cherny, R. A., Moir, R. D., Roher, A. E., White, A. R., Cappai, R., Masters, C. L., Tanzi, R. E., Inestrosa, N. C., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206428200 · Cited by 579
Marini, A., Muñoz‐Losa, A., Biancardi, A., & Mennucci, B. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp1097487 · Cited by 504
Resolving controversies on the path to Alzheimer's therapeutics
Selkoe, D. J. (2011) · Nature Medicine · doi:10.1038/nm.2460 · Cited by 494
Ran, C., Xu, X., Raymond, S. B., Ferrara, B. J., Neal, K., Bacskai, B. J., Medarova, Z., & Moore, A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9047043 · Cited by 486
Self-citationStructure-based design of non-natural amino-acid inhibitors of amyloid fibril formation
Sievers, S. A., Karanicolas, J., Chang, H. W., Zhao, A., Jiang, L., Zirafi, O., Stevens, J. T., Münch, J., Baker, D., & Eisenberg, D. (2011) · Nature · doi:10.1038/nature10154 · Cited by 460
The use of PET in Alzheimer disease
Nordberg, A., Rinne, J. O., Kadir, A., & Långström, B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.217 · Cited by 449
Small-molecule conversion of toxic oligomers to nontoxic β-sheet–rich amyloid fibrils
Bieschke, J., Herbst, M., Wiglenda, T., Friedrich, R. P., Boeddrich, A., Schiele, F., Kleckers, D., Lopez del Amo, J. M., Grüning, B. A., Wang, Q., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.719 · Cited by 445
Preclinical Properties of 18F-AV-45: A PET Agent for Aβ Plaques in the Brain
Choi, S. R., Golding, G., Zhuang, Z., Zhang, W., Lim, N., Hefti, F., Benedum, T. E., Kilbourn, M. R., Skovronsky, D., & Kung, H. F. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.065284 · Cited by 431
Atomic-resolution dynamics on the surface of amyloid-β protofibrils probed by solution NMR
Fawzi, N. L., Ying, J., Ghirlando, R., Torchia, D. A., & Clore, G. M. (2011) · Nature · doi:10.1038/nature10577 · Cited by 419
PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses
Faux, N. G., Ritchie, C. W., Gunn, A., Rembach, A., Tsatsanis, A., Bedo, J., Harrison, J., Lannfelt, L., Blennow, K., Zetterberg, H., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1390 · Cited by 405
Klunk, W. E., Lopresti, B. J., Ikonomovic, M. D., Lefterov, I. M., Koldamova, R. P., Abrahamson, E. E., Debnath, M. L., Holt, D. P., Huang, G.-F., Shao, L., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2990-05.2005 · Cited by 377
Copper Mediates Dityrosine Cross-Linking of Alzheimer's Amyloid-β
Atwood, C. S., Perry, G., Zeng, H., Kato, Y., Jones, W. D., Ling, K.-Q., Huang, X., Moir, R. D., Wang, D., Sayre, L. M., et al. (2004) · Biochemistry · doi:10.1021/bi0358824 · Cited by 371
McLaurin, J., Kierstead, M. E., Brown, M. E., Hawkes, C. A., Lambermon, M. H. L., Phinney, A. L., Darabie, A. A., Cousins, J. E., French, J. E., Lan, M. F., et al. (2006) · Nature Medicine · doi:10.1038/nm1423 · Cited by 368
In vivo detection of amyloid-β deposits by near-infrared imaging using an oxazine-derivative probe
Hintersteiner, M., Enz, A., Frey, P., Jaton, A.-L., Kinzy, W., Kneuer, R., Neumann, U., Rudin, M., Staufenbiel, M., Stoeckli, M., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1085 · Cited by 341
19F and 1H MRI detection of amyloid β plaques in vivo
Higuchi, M., Iwata, N., Matsuba, Y., Sato, K., Sasamoto, K., & Saido, T. C. (2005) · Nature Neuroscience · doi:10.1038/nn1422 · Cited by 339
Cao, D., Lu, H., Lewis, T. L., & Li, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703561200 · Cited by 336
A New Structural Model of Aβ40 Fibrils
Bertini, I., Gonnelli, L., Luchinat, C., Mao, J., & Nesi, A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2035859 · Cited by 308
Maeda, J., Ji, B., Irie, T., Tomiyama, T., Maruyama, M., Okauchi, T., Staufenbiel, M., Iwata, N., Ono, M., Saido, T. C., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0673-07.2007 · Cited by 300
Sinha, S., Lopes, D. H. J., Du, Z., Pang, E. S., Shanmugam, A., Lomakin, A., Talbiersky, P., Tennstaedt, A., McDaniel, K., Bakshi, R., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja206279b · Cited by 299
Self-Assembly and Hydrogelation of an Amyloid Peptide Fragment
Krysmann, M. J., Castelletto, V., Kelarakis, A., Hamley, I. W., Hule, R. A., & Pochan, D. J. (2008) · Biochemistry · doi:10.1021/bi8000616 · Cited by 293
Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics
Duce, J. A., & Bush, A. I. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.003 · Cited by 283
Choi, J.-S., Braymer, J. J., Nanga, R. P. R., Ramamoorthy, A., & Lim, M. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006091107 · Cited by 264
Elucidation of Amyloid β-Protein Oligomerization Mechanisms: Discrete Molecular Dynamics Study
Urbanc, B., Betnel, M., Cruz, L., Bitan, G., & Teplow, D. B. (2010) · Journal of the American Chemical Society · doi:10.1021/ja9096303 · Cited by 237
Noy, D., Solomonov, I., Sinkevich, O., Arad, T., Kjaer, K., & Sagi, I. (2008) · Journal of the American Chemical Society · doi:10.1021/ja076282l · Cited by 215
Rodríguez-Rodríguez, C., Sánchez de Groot, N., Rimola, A., Álvarez-Larena, Á., Lloveras, V., Vidal-Gancedo, J., Ventura, S., Vendrell, J., Sodupe, M., & González-Duarte, P. (2009) · Journal of the American Chemical Society · doi:10.1021/ja806062g · Cited by 210
Towards a Pharmacophore for Amyloid
Landau, M., Sawaya, M. R., Faull, K. F., Laganowsky, A., Jiang, L., Sievers, S. A., Liu, J., Barrio, J. R., & Eisenberg, D. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001080 · Cited by 210
Small Molecule Modulators of Copper-Induced Aβ Aggregation
Hindo, S. S., Mancino, A. M., Braymer, J. J., Liu, Y., Vivekanandan, S., Ramamoorthy, A., & Lim, M. H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907045h · Cited by 203
Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide
Sharma, A. K., Pavlova, S. T., Kim, J., Finkelstein, D., Hawco, N. J., Rath, N. P., Kim, J., & Mirica, L. M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja210588m · Cited by 202
Parthasarathy, S., Long, F., Miller, Y., Xiao, Y., McElheny, D., Thurber, K., Ma, B., Nussinov, R., & Ishii, Y. (2011) · Journal of the American Chemical Society · doi:10.1021/ja1072178 · Cited by 199
Kinetics of Amyloid β Monomer-to-Oligomer Exchange by NMR Relaxation
Fawzi, N. L., Ying, J., Torchia, D. A., & Clore, G. M. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1048253 · Cited by 199
Jack, C. R., Garwood, M., Wengenack, T. M., Borowski, B., Curran, G. L., Lin, J., Adriany, G., Gröhn, O. H. J., Grimm, R., & Poduslo, J. F. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20266 · Cited by 199
Ladiwala, A. R. A., Dordick, J. S., & Tessier, P. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.173856 · Cited by 188
Copper-mediated Amyloid-β Toxicity Is Associated with an Intermolecular Histidine Bridge
Smith, D. P., Smith, D. G., Curtain, C. C., Boas, J. F., Pilbrow, J. R., Ciccotosto, G. D., Lau, T.-L., Tew, D. J., Perez, K., Wade, J. D., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600417200 · Cited by 187
Development of Positron Emission Tomography β-Amyloid Plaque Imaging Agents
Mathis, C. A., Mason, N. S., Lopresti, B. J., & Klunk, W. E. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2012.07.001 · Cited by 175
BODIPY-Based Molecular Probe for Imaging of Cerebral β-Amyloid Plaques
Ono, M., Watanabe, H., Kimura, H., & Saji, H. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3000058 · Cited by 163
Rangachari, V., Moore, B. D., Reed, D. K., Sonoda, L. K., Bridges, A. W., Conboy, E. E., Hartigan, D., & Rosenberry, T. L. (2007) · Biochemistry · doi:10.1021/bi701213s · Cited by 156
Alzheimer Disease in 2020Preprint
Holtzman, D. M., Mandelkow�, E., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011585 · Cited by 156
Transmembrane Structures for Alzheimer’s Aβ 1−42 Oligomers
Strodel, B., Lee, J. W. L., Whittleston, C. S., & Wales, D. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja103725c · Cited by 155
Himes, R. A., Park, G. Y., Siluvai, G. S., Blackburn, N. J., & Karlin, K. D. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200803908 · Cited by 149
Frydman‐Marom, A., Rechter, M., Shefler, I., Bram, Y., Shalev, D. E., & Gazit, E. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200802123 · Cited by 145
Solid‐Phase Synthesis of Styryl Dyes and their Application as Amyloid Sensors
Li, Q., Lee, J., Ha, C., Park, C. B., Yang, G., Gan, W. B., & Chang, Y. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200461600 · Cited by 142
Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers
Trippier, P. C., Labby, K. J., Hawker, D. D., Mataka, J., & Silverman, R. B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3015926 · Cited by 141
Anti-crosslinking properties of carnosine: Significance of histidine
Hobart, L. J., Seibel, I., Yeargans, G. S., & Seidler, N. W. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.05.002 · Cited by 135
Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia
Klunk, W. E. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.006 · Cited by 131
Scheidt, H. A., Morgado, I., Rothemund, S., Huster, D., & Fändrich, M. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007265 · Cited by 126
Manook, A., Yousefi, B. H., Willuweit, A., Platzer, S., Reder, S., Voß, A., Huisman, M. C., Settles, M., Neff, F., Velden, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031310 · Cited by 122
Inhibition of beta-amyloid peptide aggregation by multifunctional carbazole-based fluorophores.
Yang, W.-G., Wong, Y., Ng, O. T. W., Bai, L.-P., Kwong, D., Ke, Y., Jiang, Z.-H., Li, H.-W., Yung, K. K. L., & Wong, M. (2012) · Angewandte Chemie · doi:10.1002/anie.201104150 · Cited by 120
The Structure of the Amyloid-β Peptide High-Affinity Copper II Binding Site in Alzheimer Disease
Streltsov, V. A., Titmuss, S. J., Epa, V. C., Barnham, K. J., Masters, C. L., & Varghese, J. N. (2008) · Biophysical Journal · doi:10.1529/biophysj.108.134429 · Cited by 119
In vivo MRI and histological evaluation of brain atrophy in APP/PS1 transgenic mice
Delatour, B., Guégan, M., Volk, A., & Dhénain, M. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.04.011 · Cited by 113
Klug, G. M., Lošić, D., Supundi, Subasinghe, S., Aguilar, M., Martin, L. L., & Small, D. H. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03815.x · Cited by 109
Ubiquilin 1 Modulates Amyloid Precursor Protein Trafficking and Aβ Secretion
Hiltunen, M. O., Lu, A., Thomas, A. V., Romano, D., Kim, M., Jones, P., Xie, Z., Kounnas, M. Z., Wagner, S. L., Berezovska, O., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603106200 · Cited by 92
Kuntner, C., Kesner, A., Bauer, M., Kremslehner, R., Wanek, T., Mandler, M., Karch, R., Stanek, J., Wolf, T., Müller, M., et al. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-009-0198-z · Cited by 90
ANCA: A Family of Fluorescent Probes that Bind and Stain Amyloid Plaques in Human Tissue
Chang, W. M., Dakanali, M., Capule, C. C., Sigurdson, C. J., Yang, J., & Theodorakis, E. A. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200018v · Cited by 90
Solid-state NMR analysis of interaction sites of curcumin and 42-residue amyloid β-protein fibrils
Masuda, Y., Fukuchi, M., Yatagawa, T., Tada, M., Takeda, K., Irie, K., Akagi, K., Monobe, Y., Imazawa, T., & Takegoshi, K. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.08.052 · Cited by 90
Mechanistic Studies of Peptide Self-Assembly: Transient α-Helices to Stable β-Sheets
Liu, G., Prabhakar, A., Aucoin, D., Simon, M., Sparks, S., Robbins, K. J., Sheen, A., Petty, S. A., & Lazo, N. D. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1069882 · Cited by 87
Drugs: A tangled web of targets
Gravitz, L. (2011) · Nature · doi:10.1038/475s9a · Cited by 81
PET imaging with [18F]AV-45 in an APP/PS1-21 murine model of amyloid plaque deposition
Poisnel, G., Dhilly, M., Moustié, O., Delamare, J., Abbas, A., Guilloteau, D., & Barré, L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.12.024 · Cited by 79
Wadhwani, P., Strandberg, E., Heidenreich, N., Bürck, J., Fanghänel, S., & Ulrich, A. S. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301328f · Cited by 78
Cui, M., Ono, M., Kimura, H., Liu, B., & Saji, H. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101404k · Cited by 77
A Chemical Analog of Curcumin as an Improved Inhibitor of Amyloid Abeta Oligomerization
Orlando, R. A., Gonzales, A. M., Royer, R. E., Deck, L. M., & Jagt, D. L. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031869 · Cited by 72
β-Sheet Ligands in Action: KLVFF Recognition by Aminopyrazole Hybrid Receptors in Water
Rzepecki, P., & Schrader, T. H. (2005) · Journal of the American Chemical Society · doi:10.1021/ja045558b · Cited by 71
Clioquinol and other hydroxyquinoline derivatives inhibit Aβ(1–42) oligomer assembly
LeVine, H., Ding, Q., Walker, J. A., Voss, S. R., & Augelli‐Szafran, C. E. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.08.002 · Cited by 66
Zhang, C. M., Browne, A., Child, D. D., DiVito, J. R., Stevenson, J. A., & Tanzi, R. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.079079 · Cited by 59
Levine, H. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00246-1 · Cited by 49
Ran, C., Zhao, W., Moir, R. D., & Moore, A. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019362 · Cited by 49
Self-citationSchäfer, S., Pajonk, F., Multhaup, G., & Bayer, T. A. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0140-7 · Cited by 49
Lu, Y., Prudent, M., Qiao, L., Méndez, M. A., & Girault, H. H. (2010) · Metallomics · doi:10.1039/c004693k · Cited by 47
Structural integrity of β-sheet assembly
Marshall, K. E., & Serpell, L. C. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370671 · Cited by 45
Antzutkin, O. N., Iuga, D., Filippov, A. V., Kelly, R. T., Becker‐Baldus, J., Brown, S. P., & Dupree, R. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203595 · Cited by 45
Moore, B. D., Rangachari, V., Tay, W. M., Milkovic, N. M., & Rosenberry, T. L. (2009) · Biochemistry · doi:10.1021/bi901571t · Cited by 43
Metal homeostasis in Alzheimer’s disease
White, A. R., Barnham, K. J., & Bush, A. I. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.5.711 · Cited by 42
What is the dominant aβ species in human brain tissue? A review
Gregory, G. C., & Halliday, G. M. (2005) · Neurotoxicity Research · doi:10.1007/bf03033774 · Cited by 41
Zhou, Y., Jiang, C., Zhang, Y., Liang, Z. T., Liu, W., Wang, L., Luo, C., Zhong, T., Sun, Y. E., Zhao, L., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1000584 · Cited by 32
Self-citationCurrent neuroimaging techniques in Alzheimer's disease and applications in animal models.
Zhang, L., Chang, R. C., Chu, L., & Mak, H. K. (2012) · Europe PMC (PubMed Central) · Cited by 31
Cheng, P.-N., Spencer, R. K., Woods, R. J., Glabe, C. G., & Nowick, J. S. (2012) · Journal of the American Chemical Society · doi:10.1021/ja305416a · Cited by 28
Probing and Trapping a Sensitive Conformation: Amyloid-β Fibrils, Oligomers, and Dimers
Fawver, J. N., Duong, K. T., Wise-Scira, O., Chapa, R. P., Schall, H. E., Coskuner‐Weber, O., Zhu, X., Colom, L. V., & Murray, I. V. J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120880 · Cited by 24
Hanyu, M., Ninomiya, D., Yanagihara, R., Murashima, T., Miyazawa, T., & Yamada, T. (2005) · Journal of Peptide Science · doi:10.1002/psc.647 · Cited by 15
(1999) · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
Cited by
Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques
Condello, C., Yuan, P., Schain, A., & Grutzendler, J. (2015) · Nature Communications · doi:10.1038/ncomms7176 · Cited by 718
Fu, W., Yan, C., Guo, Z., Zhang, J., Zhang, H., Tian, H., & Zhu, W.-H. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b12820 · Cited by 444
Clinical development of curcumin in neurodegenerative disease
Hu, S., Maiti, P., Ma, Q., Zuo, X., Jones, M. R., Cole, G. M., & Frautschy, S. A. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1044981 · Cited by 179
Yang, J., Yin, W., Van, R., Yin, K., Wang, P., Zheng, C., Zhu, B., Ran, K., Zhang, C., Kumar, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17783-4 · Cited by 123
Self-citationThe Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment
Zieneldien, T., Kim, J., & Cao, C. (2022) · Geriatrics · doi:10.3390/geriatrics7020024 · Cited by 29
Metadata
- Authors
- Zhang, X., Tian, Y., Li, Z., Tian, X., Sun, H., Liu, H., Moore, A., & Ran, C.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-10-25
- Volume
- 135
- Issue
- 44
- Pages
- 16397-16409
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2001447241
- Cited by
- 354
- References
- 101
- FWCI
- 12.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
